BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $330,000 | -72.1% | 2,181 | -73.1% | 0.00% | -66.7% |
| Q2 2022 | $1,183,000 | -48.3% | 8,116 | -57.9% | 0.00% | -40.0% |
| Q1 2022 | $2,287,000 | -39.1% | 19,285 | -29.2% | 0.01% | -37.5% |
| Q4 2021 | $3,756,000 | +29.5% | 27,257 | +30.5% | 0.01% | +14.3% |
| Q3 2021 | $2,901,000 | +120.3% | 20,881 | +54.0% | 0.01% | +133.3% |
| Q2 2021 | $1,317,000 | +310.3% | 13,563 | +189.0% | 0.00% | +200.0% |
| Q1 2021 | $321,000 | – | 4,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |